A phase III, double-blind, randomized placebo-controlled

Project: Research project

Project Details

Description

A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of RO4607381 on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS)
StatusFinished
Effective start/end date7/7/086/30/13

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.